Patent holdings for IPC class A61K 31/135

Total number of patents in this class: 3012

10-year publication summary

230
218
250
297
263
263
220
227
163
51
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Antecip Bioventures II LLC
360
78
Clexio Biosciences Ltd.
101
44
Oryzon Genomics S.A.
102
34
Janssen Pharmaceutica N.V.
3234
28
LTS Lohmann Therapie-Systeme AG
685
27
The Regents of the University of California
20556
22
Tonix Pharma Ltd
59
22
The Trustees of Columbia University in the City of New York
3627
21
Teva Pharmaceutical Industries Ltd.
683
20
Novartis AG
10345
19
Teva Pharmaceuticals USA, Inc.
666
19
Douglas Pharmaceuticals Limited
55
17
Grünenthal GmbH
532
17
Revogenex Ireland Ltd.
17
17
Janssen Pharmaceuticals, Inc.
439
16
Glytech, LLC
17
15
National University Corporation Chiba University
502
14
Medisca Pharmaceutique Inc.
139
13
Esteve Pharmaceuticals, S.A.
237
13
The Board of Trustees of the Leland Stanford Junior University
6592
12
Other owners 2544